Ophthalmological symptoms of rheumatic diseases

Relevance Eye involvement in rheumatic diseases is associated with common immune mechanisms that cause inflammation not only in the joints but also in the eye structures [1]. Unique eye symptoms are often the first manifestations of diseases, which emphasizes the importance of physician awareness [2]. Rheumatoid arthritis is a chronic disease that manifests itself as erosive arthritis and systemic organ damage, which shortens life expectancy [3]. Treatment of ulcerative keratitis and necrotizing scleritis includes glucocorticoids, immunosuppressants, and genetically engineered biologics [4]. Systemic vasculitides can affect the eyes, manifesting as uveitis or scleritis. Ankylosing spondylitis affects the axial skeleton. In reactive arthritis, uveitis occurs together with conjunctivitis caused by infections. SCC is the main symptom of RA with severe consequences for the lacrimal glands. In GPA, bilateral necrotizing lesions and nodules are observed. Examination may reveal avascular areas, scleral thinning, and small corneal infiltrates [5]. Between 20% and 40% of patients with ankylosing spondylitis have episodes of uveitis. In systemic lupus erythematosus, symptoms are observed in 50% of patients. Episcleritis is recorded in 1% to 5% of patients with RA. Eye inflammation may be the first sign of GPA in 10% to 30% of patients. Diagnosis includes a thorough anamnesis, blood tests for the presence of the HLA-B27 antigen, and pelvic radiography/MRI of the sacroiliac joints to detect sacroiliitis, a key feature of SpA. Conclusion Knowledge of the ocular pathology and assessment of symptoms is critical for diagnosis and therapy. Treatment requires collaboration between an ophthalmologist and a rheumatologist. Key words: rheumatic diseases; inflammatory eye diseases

Authors

Publication Details

Journal
Modern technologies in ophtalmology
Published
2025-05-14
DOI
https://doi.org/10.25276/2312-4911-2025-2-144-145
Primary Topic
Spondyloarthritis Studies and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ophthalmological symptoms of rheumatic diseases

I. Yu. Razumova, З.В. Сурнина, L.M. Agaeva, M.S. Umalatova
Modern technologies in ophtalmology
Spondyloarthritis Studies and Treatments
article

Ophthalmological symptoms of rheumatic diseases

I. Yu. Razumova, З.В. Сурнина, L.M. Agaeva, M.S. Umalatova
article en

Abstract

Relevance Eye involvement in rheumatic diseases is associated with common immune mechanisms that cause inflammation not only in the joints but also in the eye structures [1]. Unique eye symptoms are often the first manifestations of diseases, which emphasizes the importance of physician awareness [2]. Rheumatoid arthritis is a chronic disease that manifests itself as erosive arthritis and systemic organ damage, which shortens life expectancy [3]. Treatment of ulcerative keratitis and necrotizing scleritis includes glucocorticoids, immunosuppressants, and genetically engineered biologics [4]. Systemic vasculitides can affect the eyes, manifesting as uveitis or scleritis. Ankylosing spondylitis affects the axial skeleton. In reactive arthritis, uveitis occurs together with conjunctivitis caused by infections. SCC is the main symptom of RA with severe consequences for the lacrimal glands. In GPA, bilateral necrotizing lesions and nodules are observed. Examination may reveal avascular areas, scleral thinning, and small corneal infiltrates [5]. Between 20% and 40% of patients with ankylosing spondylitis have episodes of uveitis. In systemic lupus erythematosus, symptoms are observed in 50% of patients. Episcleritis is recorded in 1% to 5% of patients with RA. Eye inflammation may be the first sign of GPA in 10% to 30% of patients. Diagnosis includes a thorough anamnesis, blood tests for the presence of the HLA-B27 antigen, and pelvic radiography/MRI of the sacroiliac joints to detect sacroiliitis, a key feature of SpA. Conclusion Knowledge of the ocular pathology and assessment of symptoms is critical for diagnosis and therapy. Treatment requires collaboration between an ophthalmologist and a rheumatologist. Key words: rheumatic diseases; inflammatory eye diseases

Modern technologies in ophtalmologyVol. 60(2)
Openalex Percentile: Top 80%
Spondyloarthritis Studies and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.